Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer.
- J. Knoll, Z. Ecseri, K. Kelemen, J. Nievel, B. Knoll
- Medicine
- Archives internationales de pharmacodynamie et de…
- 1 May 1965
Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain.
On the helical strip of a capacitance vessel, the pulmonary artery of the rabbit, phenylethylamine (PEA) and tyramine act solely via displacement of noradrenaline from their storage sites and this… Expand
Differences in some behavioural effects of deprenyl and amphetamine enantiomers in rats
- J. Tímár, Z. Gyarmati, L. Barna, B. Knoll
- Psychology, Medicine
- Physiology & Behavior
- 1 August 1996
Effects of deprenyl and amphetamine enantiomers on different behavioural patterns were compared. Whereas (+)-amphetamine in doses of 1-3 mg/kg SC, (-)-amphetamine, and (+)-deprenyl in doses of 5-20… Expand
(−)1‐(Benzofuran‐2‐yl)‐2‐propylaminopentane, [(−)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain
- J. Knoll, F. Yoneda, B. Knoll, H. Ohde, I. Miklya
- Chemistry, Medicine
- British journal of pharmacology
- 1 December 1999
The brain constituents β‐phenylethylamine (PEA) and tryptamine enhance the impulse propagation mediated transmitter release (exocytosis) from the catecholaminergic and serotoninergic neurons in the… Expand
Sexual hormones terminate in the rat: the significantly enhanced catecholaminergic/serotoninergic tone in the brain characteristic to the post-weaning period.
The amount of dopamine released from the striatum, substantia nigra and tuberculum olfactorium, noradrenaline from locus coeruleus and serotonin from the raphe, was significantly higher in four and… Expand
The effect of repeated administration of (-) deprenyl on the phenylethylamine-induced stereotypy in rats.
Phenylethylamine (PEA) in a dose of 40 mg/kg induces a moderate and short-lasting stereotype behaviour. The intensity and duration of PEA-induced stereotypy was strongly potentiated in rats with… Expand
(-)Deprenyl and (-)1-phenyl-2-propylaminopentane, [(-)PPAP], act primarily as potent stimulants of action potential-transmitter release coupling in the catecholaminergic neurons.
- J. Knoll, I. Miklya, B. Knoll, R. Marko, K. Kelemen
- Chemistry, Medicine
- Life sciences
- 2 February 1996
The activity of the catecholaminergic neurons in the rat brain is enhanced significantly 30 min after the subcutaneous injection of very small doses of (-)deprenyl (threshold doses: 0.01 mg/kg for… Expand
Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and…
- F. Yoneda, T. Moto, +4 authors J. Knoll
- Chemistry, Medicine
- Bioorganic & medicinal chemistry
- 1 May 2001
The catecholaminergic and serotoninergic neurons in the brain change their performance according to the physiological need via a catecholaminergic/serotoninergic activity enhancer (CAE/SAE)… Expand
The pharmacology of 1-phenyl-2-propylamino-pentane (PPAP), a deprenyl-derived new spectrum psychostimulant.
- J. Knoll, B. Knoll, Zoltan Toeroek, J. Tímár, S. Yasar
- Chemistry, Medicine
- Archives internationales de pharmacodynamie et de…
- 1992
The peculiar tyramine uptake inhibitory effect of (-)deprenyl prompted structure-activity relationship studies aiming to develop new spectrum central nervous system stimulants which are devoid of MAO… Expand
A pharmacological analysis elucidating why, in contrast to (-)-deprenyl (selegiline), alpha-tocopherol was ineffective in the DATATOP study.
The Parkinson Study Group who conducted the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) trial designed their study in the belief that the MAO inhibitor (-)-deprenyl… Expand